Ben Ray Luján: “When the most relevant patents for OPDIVO expire, we would fully expect biosimilars to enter the market.”

During the discussion, Senator Luján heard directly from health care leaders about the impacts of these cuts and outlined his efforts to fight back and protect access to quality, affordable health care across the state.

From boosting funding for businesses developing next-generation technologies to championing legislation to strengthen stroke prevention, I was grateful for the opportunity to share some of the work I’m leading in Washington to improve the…

The innovation and creativity that IAIA inspires to solve some of our greatest challenges – both here at home and around the world – is why I’m so proud to support this institution.

Everything that was eliminated in the ‘Big Beautiful Bill,’ the state during the special [session] said, ‘Well, we can do this for a year or two,